The tumor‐to‐liver ratio of the standardized uptake value is a useful FDG‐PET/CT parameter for predicting malignant intraductal papillary mucinous neoplasm of the pancreas
Open Access
- 23 March 2022
- journal article
- research article
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 6 (5) , 695-703
Abstract
Background: The present study aimed to investigate the efficacy of positron emission tomography with 18Fluoro‐deoxyglucose (FDG‐PET/CT) for predicting malignant intraductal papillary mucinous neoplasm (IPMN).Methods: The records of 88 patients pathologically diagnosed with IPMN after surgery at Ehime University Hospital and Ehime Prefectural Central Hospital from April 2009 to December 2020 were retrospectively reviewed. The patients’ characteristics, blood chemistry, and imaging examinations were evaluated as potential predictors of malignant IPMN. Of the PET/CT results, the maximum standardized uptake value (SUVmax) of the tumor, the tumor‐to‐blood pool ratio of the SUV (TBR), and the tumor‐to‐liver ratio of the SUV (TLR) were compared.Results: On pathology, the diagnosis was adenoma (IPMA) in 40 patients, high‐grade dysplasia (HGD) in 26 patients, and carcinoma (IPMC) in 22 patients. HGD and IPMC were defined as malignant IPMN. On multivariate analyses, TLR ≥ 1.3 and high‐risk stigmata were independent predictors of malignant IPMN (P = .001 and P = .007, respectively). When both HRS and TLR ≥ 1.3 were present, the positive predictive value for malignancy was 88.2%. Furthermore, TLR was significantly higher for patients with IPMC than with HGD (P = .039).Conclusion: TLR can be a useful predictor for differentiating benign from malignant IPMN and may be associated with postoperative outcomes.Keywords
This publication has 30 references indexed in Scilit:
- IPMN Involving the Main Pancreatic DuctAnnals of Surgery, 2015
- Long-term Prospective Cohort Study of Patients Undergoing Pancreatectomy for Intraductal Papillary Mucinous Neoplasm of the PancreasAnnals of Surgery, 2014
- Pancreatic cystic lesions: The value of contrast-enhanced endoscopic ultrasound to influence the clinical pathwayEndoscopic Ultrasound, 2014
- Improvement of Hepatic Lesion Characterization by 18F-FDG PET/CT with the Use of the Lesion to Background Liver Activity RatioClinical Nuclear Medicine, 2013
- Management of Pancreatic Intraductal Papillary Mucinous Neoplasm in an Academic Hospital (2005–2010)Pancreas, 2013
- A Prognostic Score to Predict Major Complications After PancreaticoduodenectomyAnnals of Surgery, 2011
- The Utility of F-18 FDG PET/CT in the Evaluation of Pancreatic Intraductal Papillary Mucinous NeoplasmClinical Nuclear Medicine, 2010
- Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreasOncology Reports, 2010
- 18-Fluorodeoxyglucose Positron Emission Tomography Enhances Computed Tomography Diagnosis of Malignant Intraductal Papillary Mucinous Neoplasms of the PancreasAnnals of Surgery, 2007
- Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma.British Journal of Radiology, 1999